Integra LifeSciences (IART) Tops Q4 EPS by 3c, Revenues Beat; Offers FY19 EPS Mid-Point Guidance Above Consensus, FY19 Revenue Views Below Estimates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Integra LifeSciences Holdings (NASDAQ: IART) | Delayed: 12.33 +0.49 (4.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.84 | 52 Week High | $88.86 | |||
| Open | $11.69 | 52 Week Low | $54.75 | |||
| Day High | $12.36 | P/E | N/A | |||
| Day Low | $11.66 | EPS | $-0.59 | |||
| Volume | 1,386,966 | |||||
